C J Olbricht, K M Koch. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cholesterol/metabolismCoronary Disease/prevention & controlHumansHyperlipidemias/drug therapyHyperlipidemias/etiologyHyperlipidemias/metabolismHypolipidemic Agents/therapeutic useNephrotic Syndrome/complicationsNephrotic Syndrome/metabolism
Substances: See more » Hypolipidemic AgentsCholesterol
Year: 1992 PMID: 1436302 DOI: 10.1159/000187019
Source DB: PubMed Journal: Nephron ISSN: 1660-8151 Impact factor: 2.847